SCHEMBL4136582

SCHEMBL4136582

O=C1/C(=C/c2cccc([N+](=O)[O-])c2)SC(=S)N1Cc1ccc2c(c1)OCO2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 5/20 0.61
▸ DDX3X O00571 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ ALDH1A1 P00352 3/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ MAPT P10636 2/20 0.51
▸ HTT P42858 1/20 0.51
▸ POLB P06746 2/20 0.50
▸ AKR1B1 P15121 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ CRHBP P24387 1/20 0.49
▸ CRHR2 Q13324 1/20 0.49
▸ NOD2 Q9HC29 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ CTRC Q99895 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4136588 1.00 MAPK1 (0.61) MAPK1DDX3XPKMNPSR1ALDH1A1
SCHEMBL4136593 1.00 MAPK1 (0.61) MAPK1DDX3XPKMNPSR1ALDH1A1
SCHEMBL4132061 0.91 MAPK1 (0.65) MAPK1PKMNPSR1ALDH1A1SMN1; SMN2
SCHEMBL13651178 0.91 MAPK1 (0.65) MAPK1PKMNPSR1ALDH1A1SMN1; SMN2
SCHEMBL4132059 0.91 MAPK1 (0.65) MAPK1PKMNPSR1ALDH1A1SMN1; SMN2
SCHEMBL4141542 0.86 MAPK1 (0.53) MAPK1PKMNPSR1ALDH1A1SMN1; SMN2
SCHEMBL4141548 0.86 MAPK1 (0.53) MAPK1PKMNPSR1ALDH1A1SMN1; SMN2
SCHEMBL13651175 0.86 MAPK1 (0.53) MAPK1PKMNPSR1ALDH1A1SMN1; SMN2
SCHEMBL4142283 0.86 MAPK1 (0.67) MAPK1DDX3XMEN1KMT2APOLB
SCHEMBL4142279 0.86 MAPK1 (0.67) MAPK1DDX3XMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 MAPK1 3035/4885DDX3X 348/4885PKM 2638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback